Welcome back to the buzz, our monthly cannabis news and policy update. Your at-a-glance source for regulatory developments, agency announcements, and trends impacting the cannabis industry.
In this edition of the buzz,...more
Welcome back to the buzz, our monthly cannabis news and policy update. Your at-a-glance source for regulatory developments, agency announcements, and trends impacting the cannabis industry.
In this edition of the buzz,...more
1/23/2025
/ Banking Sector ,
Cannabis-Related Businesses (CRBs) ,
Controlled Substances ,
Corporate Transparency Act ,
DEA ,
Department of Justice (DOJ) ,
Hemp ,
Internal Revenue Code (IRC) ,
IRS ,
Marijuana ,
Medical Marijuana ,
Recreational Use ,
Tax Court ,
Tax Planning
Welcome back to the buzz, our monthly cannabis news and policy update. Your at-a-glance source for regulatory developments, agency announcements, and trends impacting the cannabis industry.
In this edition of the buzz,...more
12/19/2024
/ Administrative Law Judge (ALJ) ,
Cannabis Products ,
Corporate Transparency Act ,
DEA ,
FinCEN ,
Hemp ,
IRS ,
Liability ,
Medicaid ,
Medical Marijuana ,
Medicare ,
Schedule I Drugs ,
Tax Returns
Welcome back to the buzz, our monthly cannabis news and policy update. Your at-a-glance source for regulatory developments, agency announcements, and trends impacting the cannabis industry.
This month's highlights include:...more
9/20/2024
/ Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Controlled Substances Act ,
DEA ,
Delaware ,
Final Rules ,
Hemp ,
Hemp Related Businesses ,
Licensing Rules ,
Notice of Intent ,
Schedule I Drugs
The DEA announced on Tuesday it will accept the Health and Human Services Department’s (HHS) recommendation to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act.
This move will have a...more
Based on a news report from Bloomberg earlier this morning, the Department of Health and Human Services (HHS) has recommended to the Drug Enforcement Agency (DEA) that marijuana be reclassified as a Schedule III drug under...more